[Phe3]OT [6321]
[Phe3]OT
| SMILES | CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O |
| InChIKey | WTHKESHUHBGMGM-DZCXQCEKSA-N |
| Sequence | CYFQNCPLG |
| HELM | PEPTIDE1{C.Y.F.Q.N.C.P.L.G.[am]}$PEPTIDE1,PEPTIDE1,6:R3-1:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors | 15 |
| Hydrogen bond donors | 12 |
| Rotatable bonds | 17 |
| Log P | -3.412 |
| Molecular weight (Da) | 1040.4 |
| Stereochemistry info | unspecified |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
[Phe3]OT
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0